HEALTH Minister Greg Hunt has announced the Pharmaceutical Benefits Scheme (PBS) listing of medicines to treat lung cancer, lymphoblastic acute leukaemia and severe nausea associated with chemotherapy, effective today.
Tecentriq (atezolizumab), Avastin (bevacizumab), Besponsa (inotuzumab ozogamicin) and Blincyto (blinatumomab) were named along with cuts to pregabalin and some ezetimibe products.
The latest round of PBS Price Disclosure cuts has also been confirmed.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Oct 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Oct 19